Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme
- Conditions
- Hypertension
- Interventions
- Behavioral: Resistance training
- Registration Number
- NCT01963507
- Lead Sponsor
- Federal University of São Paulo
- Brief Summary
The study aimed to evaluate the chronic effects of resistance training on blood pressure and biochemical exams in hypertensive elderlies and the influence of the polymorphism of the angiotensin converting enzyme in these response.
- Detailed Description
To investigate the chronic effects of resistance training on blood pressure and biochemical exams in elderly, 135 hypertensive elderlies were divided into 2 groups: trained and control. The trained group was submitted to a resistance training period. Before the 16 weeks ACE gene was genotyped (PCR). Before and after 16 weeks, blood pressure (ambulatory), HDL-cholesterol, Total cholesterol, Glycemia, Triacylglycerol (colorimetric assay) and plasminogen activator inhibition (PAI-1), intercellular adhesion molecule (ICAM-1), vascular endothelial cell adhesion molecule (VCAM-1), Adiponectin, tumor necrosis factor alpha (TNF-alpha), C Reactive Protein, Angiotensin II, Angiotensin Converting Enzyme, Angiotensin 1-7, (ELISA assay) were measured.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 136
- Hypertensives
- Age 60 to 85 years
- Nonactive
- Orthopedic problems or other problem that prevented the exercises
- Change in drug treatment during protocol
- Absence in more than 25% of the exercise sessions
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Resistance training Resistance training Resistance training performed three times at week for 16 weeks, in 8 exercises for the main muscles, the protocol of 3 sets of 10 repetitions with intensity of 50% of 1 maximum repetition (MR).
- Primary Outcome Measures
Name Time Method Blood Pressure 16 weeks Blood pressure was measured by Ambulatorial Monitoring Blood Pressure before and after 16 weeks of intervention.
- Secondary Outcome Measures
Name Time Method Total Cholesterol 16 weeks Total cholesterol was analyzed by colorimetric assay, before and after 16 weeks of intervention.
Glycemia 16 weeks Glycemia was analyzed by colorimetric assay, before and after 16 weeks of intervention.
HDL-cholesterol 16 weeks HDL-cholesterol was analyzed by colorimetric assay, before and after 16 weeks of intervention.
Triacylglycerol 16 weeks Triacylglycerol was analyzed by colorimetric assay, before and after 16 weeks of intervention.
PAI-1 16 weeks PAI-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.
ICAM-1 16 weeks ICAM-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.
VCAM-1 16 weeks VCAM-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.
Adiponectin 16 weeks Adiponectin was analyzed by ELISA assay, before and after 16 weeks of intervention.
TNF alpha 16 weeks TNF alpha was analyzed by ELISA assay, before and after 16 weeks of intervention.
C Reactive Protein 16 weeks C Reactive Protein was analyzed by ELISA assay, before and after 16 weeks of intervention.
Angiotensin II 16 weeks Angiotensin II was analyzed by ELISA assay, before and after 16 weeks of intervention.
Angiotensin Converting Enzyme 16 weeks Angiotensin Converting Enzyme was analyzed by ELISA assay, before and after 16 weeks of intervention.
Angiotensin 1-7 16 weeks Angiotensin 1-7 was analyzed by ELISA assay, before and after 16 weeks of intervention.
Trial Locations
- Locations (1)
UNIMED
🇧🇷Santos, SP, Brazil